NTLA
WATCH Intellia Therapeutics, Inc. · US
—
—
Prices as of close 2026-07-28
CRISPR leader with meaningful pipeline optionality and high-reward catalyst potential over the next year.
Buy signals
- ▸Morningstar lists it among most undervalued biotech names.
Related Biotech picks
AI-generated research for educational purposes only — not investment advice. Prices are end-of-day.